Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies

OBJECTIVE: Tofacitinib is an oral Janus kinase for the treatment of rheumatoid arthritis (RA). This post hoc analysis assessed whether baseline body mass index (BMI) impacts tofacitinib efficacy in patients with RA. METHODS: Pooled data from six phase 3 studies in patients receiving tofacitinib 5 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Dikranian, Ara H, Gonzalez-Gay, Miguel A, Wellborne, Frank, Álvaro-Gracia, José María, Takiya, Liza, Stockert, Lori, Paulissen, Jerome, Shi, Harry, Tatulych, Svitlana, Curtis, Jeffrey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114845/
https://www.ncbi.nlm.nih.gov/pubmed/35577477
http://dx.doi.org/10.1136/rmdopen-2021-002103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114845/
https://www.ncbi.nlm.nih.gov/pubmed/35577477
http://dx.doi.org/10.1136/rmdopen-2021-002103

Ejemplares similares